Drug Shortage Report for METHOXISAL-C 1/2
| Report ID | 8017 |
| Drug Identification Number | 01966375 |
| Brand name | METHOXISAL-C 1/2 |
| Common or Proper name | METHOXISAL |
| Company Name | TEVA CANADA LIMITED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ACETYLSALICYLIC ACID METHOCARBAMOL CODEINE PHOSPHATE |
| Strength(s) | 325MG 400MG 32.4MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | N02AA |
| ATC description | OPIOIDS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2013-03-01 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2017-10-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2017-04-25 | French | Compare |
| v1 | 2017-04-25 | English | Compare |
Showing 1 to 2 of 2